WO1999022703A1 - Improved personal care formulations - Google Patents
Improved personal care formulations Download PDFInfo
- Publication number
- WO1999022703A1 WO1999022703A1 PCT/IL1998/000504 IL9800504W WO9922703A1 WO 1999022703 A1 WO1999022703 A1 WO 1999022703A1 IL 9800504 W IL9800504 W IL 9800504W WO 9922703 A1 WO9922703 A1 WO 9922703A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formulation
- lipid
- group
- agent
- carrier
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0291—Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020007004673A KR20010031621A (en) | 1997-10-31 | 1998-10-18 | Improved Personal Care Formulations |
AU95587/98A AU758188B2 (en) | 1997-10-31 | 1998-10-18 | Improved personal care formulations |
JP2000518642A JP2001521882A (en) | 1997-10-31 | 1998-10-18 | Improved personal care composition |
EP98949227A EP1027029A4 (en) | 1997-10-31 | 1998-10-18 | Improved personal care formulations |
CA002307886A CA2307886A1 (en) | 1997-10-31 | 1998-10-18 | Improved personal care formulations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12208497A IL122084A (en) | 1997-10-31 | 1997-10-31 | Formulation for personal care with mucoadhesive properties |
IL122084 | 1997-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999022703A1 true WO1999022703A1 (en) | 1999-05-14 |
Family
ID=11070803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL1998/000504 WO1999022703A1 (en) | 1997-10-31 | 1998-10-18 | Improved personal care formulations |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1027029A4 (en) |
JP (1) | JP2001521882A (en) |
KR (1) | KR20010031621A (en) |
CN (1) | CN1283983A (en) |
AU (1) | AU758188B2 (en) |
CA (1) | CA2307886A1 (en) |
IL (1) | IL122084A (en) |
WO (1) | WO1999022703A1 (en) |
Cited By (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000066070A2 (en) * | 1999-04-30 | 2000-11-09 | Henkel Kommanditgesellschaft Auf Aktien | Utilization of nanoscalar, antimicrobial active ingredients in oral and/or dental hygiene |
DE19931308A1 (en) * | 1999-07-07 | 2001-01-11 | Beiersdorf Ag | Deodorising and / or antiperspirant preparations containing bioquinones |
WO2001019403A1 (en) * | 1999-09-14 | 2001-03-22 | Lim Jung Ok | Liposomal mixture of local anesthetics and manufacturing method thereof |
WO2001019362A2 (en) * | 1999-09-14 | 2001-03-22 | Orapharma, Inc. | Formulations for treating or preventing mucositis |
WO2001066085A2 (en) * | 2000-03-06 | 2001-09-13 | Generex Pharmaceuticals Inc. | Micellar pharmaceutical compositions for buccal and pulmonary application |
WO2001087268A1 (en) * | 2000-05-19 | 2001-11-22 | Generex Pharmaceuticals Inc. | Micellar pharmaceutical compositions for buccal and pulmonary application |
US6436369B2 (en) * | 1998-12-17 | 2002-08-20 | Wm. Wrigley Jr. Company | Anti-plaque emulsions and products containing same |
WO2002092067A1 (en) * | 2001-05-10 | 2002-11-21 | Kaneka Corporation | Compositions for transmucosal administration containing coenzyme q as the active ingredient |
JP2003026567A (en) * | 2001-05-10 | 2003-01-29 | Kanegafuchi Chem Ind Co Ltd | Composition for administration to mucosa and containing coenzyme q as active ingredient |
WO2004075877A1 (en) * | 2003-02-24 | 2004-09-10 | Pharmaceutical Productions, Inc. | Transmucosal drug delivery system |
WO2005002535A1 (en) * | 2003-07-03 | 2005-01-13 | Betafarma S.P.A. | Antibacterial mouthwash |
US6849263B2 (en) | 1998-12-21 | 2005-02-01 | Generex Pharmaceutical Incorporated | Pharmaceutical compositions for buccal delivery of pain relief medications |
FR2861297A1 (en) * | 2003-10-23 | 2005-04-29 | Oreal | COSMETIC OR DERMATOLOGICAL H / E EMULSION OF STABLE PH |
US6893665B2 (en) | 1999-09-14 | 2005-05-17 | Orapharma, Inc. | Formulations for treating or preventing mucositis |
WO2006029278A2 (en) * | 2004-09-07 | 2006-03-16 | 3M Innovative Properties Company | Phenolic antiseptic compositions and methods of use |
US7087215B2 (en) | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
EP1767246A1 (en) * | 2005-09-26 | 2007-03-28 | GC Corporation | Composition for moistening oral cavity |
EP1829546A1 (en) * | 1999-09-14 | 2007-09-05 | Mucosal Therapeutics LLC | Formulations containing tetracyclines for treating or preventing mucositis |
WO2009106338A2 (en) * | 2008-02-29 | 2009-09-03 | Lipotec, S.A. | Cosmetic of dermopharmaceutical composition of mixed micelles |
DE102010013081A1 (en) * | 2010-03-26 | 2011-09-29 | B. Braun Melsungen Ag | Antimicrobial oil in water emulsion |
WO2011128597A1 (en) * | 2010-04-16 | 2011-10-20 | Xeda International | Novel formulations of active ingredient(s) of plant origin or synthetic analogues thereof or of extract(s) of plant origin containing same, and of lecithin |
WO2011157428A3 (en) * | 2010-06-16 | 2012-07-26 | F. Holzer Gmbh | In-situ lecithin microemulsion gel formulation |
US8236288B2 (en) | 2011-01-07 | 2012-08-07 | Skinmedica, Inc. | Melanin modification compositions and methods of use |
US8246969B2 (en) | 2001-11-16 | 2012-08-21 | Skinmedica, Inc. | Compositions containing aromatic aldehydes and their use in treatments |
US8623935B2 (en) | 2007-12-31 | 2014-01-07 | 3M Innovative Properties Company | Antimicrobial compositions |
US8802116B2 (en) | 2003-02-27 | 2014-08-12 | Novasel Australia Pty. Ltd. | Poloxamer emulsion preparations |
US9028852B2 (en) | 2004-09-07 | 2015-05-12 | 3M Innovative Properties Company | Cationic antiseptic compositions and methods of use |
US9254294B2 (en) | 2003-02-24 | 2016-02-09 | Pharmaceutical Productions Inc. | Transmucosal hormone delivery system |
US9339553B2 (en) | 2010-09-01 | 2016-05-17 | Peking University | Liquid compositions of insoluble drugs and preparation methods thereof |
US9358296B2 (en) | 2003-02-24 | 2016-06-07 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US9498454B2 (en) | 2003-02-24 | 2016-11-22 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
WO2017001617A1 (en) * | 2015-06-30 | 2017-01-05 | Sequessome Technology Holdings Limited | Blended formulations |
US9775908B2 (en) | 2007-07-10 | 2017-10-03 | Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag | Pharmaceutical preparations containing highly volatile silicones |
US9826770B2 (en) | 2005-03-10 | 2017-11-28 | 3M Innovative Properties Company | Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US10172810B2 (en) | 2003-02-24 | 2019-01-08 | Pharmaceutical Productions, Inc. | Transmucosal ketamine delivery composition |
US10471036B2 (en) | 2003-09-09 | 2019-11-12 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
CN112137960A (en) * | 2020-09-28 | 2020-12-29 | 广州市香雪制药股份有限公司 | Essential oil liposome and preparation method and application thereof |
US10918618B2 (en) | 2005-03-10 | 2021-02-16 | 3M Innovative Properties Company | Methods of reducing microbial contamination |
US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
RU2812079C2 (en) * | 2018-12-06 | 2024-01-22 | Липикар Лайф Сайенсиз Лтд. | Vitamin d microemulsions and their applications |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2630578C (en) * | 2005-11-30 | 2014-04-15 | Generex Pharmaceuticals Inc. | Orally absorbed pharmaceutical formulation and method of administration |
ES2304103B1 (en) * | 2007-02-22 | 2009-08-07 | Biocosmetics S.L. | COMPOSITION FOR TREATMENT OF XEROSTOMY OR DRY MOUTH. |
WO2010006192A1 (en) * | 2008-07-09 | 2010-01-14 | Board Of Regents Of The University Of Nebraska | Functional micelles for hard tissue targeted delivery of chemicals |
JP6471407B2 (en) * | 2013-12-25 | 2019-02-20 | サンスター株式会社 | Oral or throat composition |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4670185A (en) * | 1982-07-19 | 1987-06-02 | Lion Corporation | Aqueous vesicle dispersion having surface charge |
US4767615A (en) * | 1984-05-03 | 1988-08-30 | Technology Unlimited, Inc. | Dental therapy by vesicle delivery |
US5128139A (en) * | 1991-02-15 | 1992-07-07 | Nu Skin International, Inc. | Composition containing liposome-entrapped grapefruit seed extract and method for making |
US5376646A (en) * | 1990-01-24 | 1994-12-27 | Hoffmann-La Roche Inc. | Topical preparations containing the salt of a cholanic acid and a lipid |
US5443840A (en) * | 1992-02-18 | 1995-08-22 | L'oreal | Cosmetic and/or pharmaceutical composition containing a dispersion of lipid vesicles, process for the preparation of the said dispersion and dispersion of lipid vesicles |
US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
US5679374A (en) * | 1993-12-30 | 1997-10-21 | L'oreal | Anti-acne composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8501015D0 (en) * | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
US5338761A (en) * | 1988-09-29 | 1994-08-16 | Shiseido Company Ltd. | Emulsified composition |
-
1997
- 1997-10-31 IL IL12208497A patent/IL122084A/en not_active IP Right Cessation
-
1998
- 1998-10-18 KR KR1020007004673A patent/KR20010031621A/en not_active Application Discontinuation
- 1998-10-18 CN CN98811388A patent/CN1283983A/en active Pending
- 1998-10-18 WO PCT/IL1998/000504 patent/WO1999022703A1/en not_active Application Discontinuation
- 1998-10-18 EP EP98949227A patent/EP1027029A4/en not_active Withdrawn
- 1998-10-18 CA CA002307886A patent/CA2307886A1/en not_active Abandoned
- 1998-10-18 AU AU95587/98A patent/AU758188B2/en not_active Ceased
- 1998-10-18 JP JP2000518642A patent/JP2001521882A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4670185A (en) * | 1982-07-19 | 1987-06-02 | Lion Corporation | Aqueous vesicle dispersion having surface charge |
US4767615A (en) * | 1984-05-03 | 1988-08-30 | Technology Unlimited, Inc. | Dental therapy by vesicle delivery |
US5376646A (en) * | 1990-01-24 | 1994-12-27 | Hoffmann-La Roche Inc. | Topical preparations containing the salt of a cholanic acid and a lipid |
US5128139A (en) * | 1991-02-15 | 1992-07-07 | Nu Skin International, Inc. | Composition containing liposome-entrapped grapefruit seed extract and method for making |
US5443840A (en) * | 1992-02-18 | 1995-08-22 | L'oreal | Cosmetic and/or pharmaceutical composition containing a dispersion of lipid vesicles, process for the preparation of the said dispersion and dispersion of lipid vesicles |
US5626868A (en) * | 1992-02-18 | 1997-05-06 | L'oreal | Cosmetic and/or pharmaceutical composition containing a dispersion of lipid vesicles, process for the preparation of the said dispersion and dispersion of lipid vesicles |
US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
US5662932A (en) * | 1993-05-18 | 1997-09-02 | Pharmos Corporation | Solid fat nanoemulsions |
US5679374A (en) * | 1993-12-30 | 1997-10-21 | L'oreal | Anti-acne composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof |
Non-Patent Citations (1)
Title |
---|
See also references of EP1027029A4 * |
Cited By (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6436369B2 (en) * | 1998-12-17 | 2002-08-20 | Wm. Wrigley Jr. Company | Anti-plaque emulsions and products containing same |
US6849263B2 (en) | 1998-12-21 | 2005-02-01 | Generex Pharmaceutical Incorporated | Pharmaceutical compositions for buccal delivery of pain relief medications |
US7087215B2 (en) | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
US6451286B1 (en) | 1998-12-21 | 2002-09-17 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
WO2000066070A2 (en) * | 1999-04-30 | 2000-11-09 | Henkel Kommanditgesellschaft Auf Aktien | Utilization of nanoscalar, antimicrobial active ingredients in oral and/or dental hygiene |
WO2000066070A3 (en) * | 1999-04-30 | 2001-04-05 | Henkel Kgaa | Utilization of nanoscalar, antimicrobial active ingredients in oral and/or dental hygiene |
DE19931308A1 (en) * | 1999-07-07 | 2001-01-11 | Beiersdorf Ag | Deodorising and / or antiperspirant preparations containing bioquinones |
WO2001019362A2 (en) * | 1999-09-14 | 2001-03-22 | Orapharma, Inc. | Formulations for treating or preventing mucositis |
WO2001019362A3 (en) * | 1999-09-14 | 2001-12-13 | Orapharma Inc | Formulations for treating or preventing mucositis |
EP1829546A1 (en) * | 1999-09-14 | 2007-09-05 | Mucosal Therapeutics LLC | Formulations containing tetracyclines for treating or preventing mucositis |
US6946118B1 (en) | 1999-09-14 | 2005-09-20 | Orapharma, Inc. | Formulations for treating or preventing mucositis |
US6893665B2 (en) | 1999-09-14 | 2005-05-17 | Orapharma, Inc. | Formulations for treating or preventing mucositis |
WO2001019403A1 (en) * | 1999-09-14 | 2001-03-22 | Lim Jung Ok | Liposomal mixture of local anesthetics and manufacturing method thereof |
WO2001066085A3 (en) * | 2000-03-06 | 2002-04-11 | Generex Pharm Inc | Micellar pharmaceutical compositions for buccal and pulmonary application |
WO2001066085A2 (en) * | 2000-03-06 | 2001-09-13 | Generex Pharmaceuticals Inc. | Micellar pharmaceutical compositions for buccal and pulmonary application |
WO2001087268A1 (en) * | 2000-05-19 | 2001-11-22 | Generex Pharmaceuticals Inc. | Micellar pharmaceutical compositions for buccal and pulmonary application |
JP2003026567A (en) * | 2001-05-10 | 2003-01-29 | Kanegafuchi Chem Ind Co Ltd | Composition for administration to mucosa and containing coenzyme q as active ingredient |
WO2002092067A1 (en) * | 2001-05-10 | 2002-11-21 | Kaneka Corporation | Compositions for transmucosal administration containing coenzyme q as the active ingredient |
AU2002309038B2 (en) * | 2001-05-10 | 2007-05-17 | Kaneka Corporation | Compositions for transmucosal administration containing coenzyme Q as the active ingredient |
US7754205B2 (en) | 2001-05-10 | 2010-07-13 | Kaneka Corporation | Composition for transmucosal administration containing conenzyme Q as the active ingredient |
US9895361B2 (en) | 2001-11-16 | 2018-02-20 | Allergan, Inc. | Compositions containing aromatic aldehydes and their use in treatments |
US10702515B2 (en) | 2001-11-16 | 2020-07-07 | Allergan, Inc. | Compositions containing aromatic aldehydes and their use in treatments |
US9107874B2 (en) | 2001-11-16 | 2015-08-18 | Allergan, Inc. | Compositions containing aromatic aldehydes and their use in treatments |
US8496951B2 (en) | 2001-11-16 | 2013-07-30 | Allergan, Inc. | Compositions containing aromatic aldehydes and their use in treatments |
US8268336B2 (en) | 2001-11-16 | 2012-09-18 | Skinmedica, Inc. | Compositions containing aromatic aldehydes and their use in treatments |
US8246971B2 (en) | 2001-11-16 | 2012-08-21 | Skinmedica, Inc. | Compositions containing aromatic aldehydes and their use in treatment |
US8246969B2 (en) | 2001-11-16 | 2012-08-21 | Skinmedica, Inc. | Compositions containing aromatic aldehydes and their use in treatments |
US9498454B2 (en) | 2003-02-24 | 2016-11-22 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US9549897B2 (en) | 2003-02-24 | 2017-01-24 | Pharmaceutical Productions, Inc. | Transmucosal hormone delivery system |
US8992974B2 (en) | 2003-02-24 | 2015-03-31 | Pharmaceuticals Productions, Inc. | Transmucosal drug delivery system |
EP2316418A3 (en) * | 2003-02-24 | 2011-09-21 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
EP2343045A3 (en) * | 2003-02-24 | 2011-09-21 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
WO2004075877A1 (en) * | 2003-02-24 | 2004-09-10 | Pharmaceutical Productions, Inc. | Transmucosal drug delivery system |
US10172810B2 (en) | 2003-02-24 | 2019-01-08 | Pharmaceutical Productions, Inc. | Transmucosal ketamine delivery composition |
US9254294B2 (en) | 2003-02-24 | 2016-02-09 | Pharmaceutical Productions Inc. | Transmucosal hormone delivery system |
US9358296B2 (en) | 2003-02-24 | 2016-06-07 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US8802116B2 (en) | 2003-02-27 | 2014-08-12 | Novasel Australia Pty. Ltd. | Poloxamer emulsion preparations |
WO2005002535A1 (en) * | 2003-07-03 | 2005-01-13 | Betafarma S.P.A. | Antibacterial mouthwash |
US10471036B2 (en) | 2003-09-09 | 2019-11-12 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
FR2861297A1 (en) * | 2003-10-23 | 2005-04-29 | Oreal | COSMETIC OR DERMATOLOGICAL H / E EMULSION OF STABLE PH |
WO2006029278A3 (en) * | 2004-09-07 | 2006-09-14 | 3M Innovative Properties Co | Phenolic antiseptic compositions and methods of use |
WO2006029278A2 (en) * | 2004-09-07 | 2006-03-16 | 3M Innovative Properties Company | Phenolic antiseptic compositions and methods of use |
US10016501B2 (en) | 2004-09-07 | 2018-07-10 | 3M Innovative Properties Company | Cationic antiseptic compositions and methods of use |
US9028852B2 (en) | 2004-09-07 | 2015-05-12 | 3M Innovative Properties Company | Cationic antiseptic compositions and methods of use |
US9826770B2 (en) | 2005-03-10 | 2017-11-28 | 3M Innovative Properties Company | Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
US10918618B2 (en) | 2005-03-10 | 2021-02-16 | 3M Innovative Properties Company | Methods of reducing microbial contamination |
JP2007084501A (en) * | 2005-09-26 | 2007-04-05 | Gc Corp | Composition for wetting oral cavity |
EP1767246A1 (en) * | 2005-09-26 | 2007-03-28 | GC Corporation | Composition for moistening oral cavity |
US9775908B2 (en) | 2007-07-10 | 2017-10-03 | Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag | Pharmaceutical preparations containing highly volatile silicones |
US8623935B2 (en) | 2007-12-31 | 2014-01-07 | 3M Innovative Properties Company | Antimicrobial compositions |
WO2009106338A2 (en) * | 2008-02-29 | 2009-09-03 | Lipotec, S.A. | Cosmetic of dermopharmaceutical composition of mixed micelles |
ES2335636A1 (en) * | 2008-02-29 | 2010-03-30 | Lipotec, S.A. | Cosmetic of dermopharmaceutical composition of mixed micelles |
WO2009106338A3 (en) * | 2008-02-29 | 2010-02-25 | Lipotec, S.A. | Cosmetic of dermopharmaceutical composition of mixed micelles |
DE102010013081A1 (en) * | 2010-03-26 | 2011-09-29 | B. Braun Melsungen Ag | Antimicrobial oil in water emulsion |
FR2958851A1 (en) * | 2010-04-16 | 2011-10-21 | Xeda International | NEW ACTIVE INGREDIENT (S) FORMULATIONS OF VEGETABLE ORIGIN OR THEIR SYNTHETIC OR PLANT EXTRACT (S) CONTAINING THEM, AND LECITHIN |
WO2011128597A1 (en) * | 2010-04-16 | 2011-10-20 | Xeda International | Novel formulations of active ingredient(s) of plant origin or synthetic analogues thereof or of extract(s) of plant origin containing same, and of lecithin |
WO2011157428A3 (en) * | 2010-06-16 | 2012-07-26 | F. Holzer Gmbh | In-situ lecithin microemulsion gel formulation |
US9339553B2 (en) | 2010-09-01 | 2016-05-17 | Peking University | Liquid compositions of insoluble drugs and preparation methods thereof |
US9044404B2 (en) | 2011-01-07 | 2015-06-02 | Allergan, Inc. | Melanin modification compositions and methods of use |
US8778315B2 (en) | 2011-01-07 | 2014-07-15 | Allergan, Inc. | Melanin modification compositions and methods of use |
US8236288B2 (en) | 2011-01-07 | 2012-08-07 | Skinmedica, Inc. | Melanin modification compositions and methods of use |
US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
WO2017001617A1 (en) * | 2015-06-30 | 2017-01-05 | Sequessome Technology Holdings Limited | Blended formulations |
EA038613B1 (en) * | 2015-06-30 | 2021-09-23 | Секвессом Текнолоджи Холдингс Лимитед | Blended formulations |
US10744090B2 (en) | 2015-06-30 | 2020-08-18 | Sequessome Technology Holdings Limited | Multiphasic compositions |
US11547665B2 (en) | 2015-06-30 | 2023-01-10 | Sequessome Technology Holdings Limited | Multiphasic compositions |
RU2812079C2 (en) * | 2018-12-06 | 2024-01-22 | Липикар Лайф Сайенсиз Лтд. | Vitamin d microemulsions and their applications |
CN112137960A (en) * | 2020-09-28 | 2020-12-29 | 广州市香雪制药股份有限公司 | Essential oil liposome and preparation method and application thereof |
CN112137960B (en) * | 2020-09-28 | 2022-12-20 | 广州市香雪制药股份有限公司 | Essential oil liposome and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1283983A (en) | 2001-02-14 |
IL122084A0 (en) | 1998-03-10 |
EP1027029A4 (en) | 2005-09-07 |
IL122084A (en) | 1999-09-22 |
CA2307886A1 (en) | 1999-05-14 |
AU9558798A (en) | 1999-05-24 |
KR20010031621A (en) | 2001-04-16 |
EP1027029A1 (en) | 2000-08-16 |
JP2001521882A (en) | 2001-11-13 |
AU758188B2 (en) | 2003-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU758188B2 (en) | Improved personal care formulations | |
US6861060B1 (en) | Personal care formulations | |
EP2537514B1 (en) | Antimicrobial preparations having a content of octenidine dihydrochloride encapsulated in liposomes | |
JP2947668B2 (en) | Topical formulations containing suspensions of solid lipid particles | |
JPH10500686A (en) | Antibacterial oil-in-water emulsion | |
IL129921A (en) | Topical and transdermal delivery compositions utilizing submicron oil droplets and these compositions comprising an active ingredient | |
JP2003533491A (en) | Pharmaceutical and / or cosmetic composition | |
JPH06279230A (en) | Cosmetic composition for providing salicylic acid and preparation thereof | |
JP2001501625A (en) | Cosmetic composition | |
EP0611207A1 (en) | Process for stabilisation of vesicles of amphiphilic lipids and composition for topical application containing these stabilized vesicles | |
CN103037867A (en) | Borinic compositions | |
JP2677576B2 (en) | Phospholipid transport vehicle for water-insoluble active ingredients | |
HUT73531A (en) | Ketoprofene liposomes | |
JPH07503953A (en) | Liposomal itraconazole composition | |
JPH07503952A (en) | Liposomal piroxicam composition | |
DE69813287T2 (en) | LIPID COMPOSITIONS AND THEIR USE | |
EP1364642B1 (en) | Composition for delivery of dithranol | |
JP2557557B2 (en) | Pharmaceutical composition for topical administration containing piroxicam | |
CA2416731C (en) | Liposomal formulation of clobetasol propionate | |
JP6322575B2 (en) | Topical formulation containing lipid microcapsule delivery vehicle and use thereof | |
EP2255790B1 (en) | Liposome composition comprising naproxen, and a method of obtaining same | |
JPH05506671A (en) | Drugs to treat viral diseases | |
JP2747317B2 (en) | Drugs that maintain or restore skin health | |
IE920401A1 (en) | Pharmaceutical product for the treatment of virus diseases | |
EP1809244B1 (en) | Retinoid solutions and formulations made therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 98811388.0 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2307886 Country of ref document: CA Ref document number: 2307886 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020007004673 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 95587/98 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998949227 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998949227 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1020007004673 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 95587/98 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020007004673 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998949227 Country of ref document: EP |